Johnson & Johnson

JNJ-N

NYSE:JNJ

134.17
1.02 (0.77%)
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
More at Wikipedia

Analysis and Opinions about JNJ-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
September 20, 2002
(Was a top pick on July 17. No change.) Still likes. A core holding.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
September 20, 2002
(Was a top pick on July 17. No change.) Still likes. A core holding.
DON'T BUY
DON'T BUY
August 16, 2002
Expensive now. Good long term hold.
Show full opinionHide full opinion
Expensive now. Good long term hold.
TOP PICK
TOP PICK
July 17, 2002
Great price. Should appreciate 15% a year. Good numbers.
Show full opinionHide full opinion
Great price. Should appreciate 15% a year. Good numbers.
BUY
BUY
July 10, 2002
A good long term hold. Good price.
Show full opinionHide full opinion
A good long term hold. Good price.
WAIT
WAIT
June 28, 2002
Benefiting from weaker US $. Wait for it to reverse its down trend.
Show full opinionHide full opinion
Benefiting from weaker US $. Wait for it to reverse its down trend.
BUY
BUY
May 30, 2002
Bullish. International.No generic drug problems. Good cash flow from a lot of coonsumer products.
Show full opinionHide full opinion
Bullish. International.No generic drug problems. Good cash flow from a lot of coonsumer products.
DON'T BUY
DON'T BUY
April 19, 2002
Great company, but expensive.
Show full opinionHide full opinion
Great company, but expensive.
BUY
BUY
February 22, 2002
Prefers this and Pfizer over Merk.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 22, 2002
Prefers this and Pfizer over Merk.
BUY
BUY
January 22, 2002
Some good products. Grows well.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
January 22, 2002
Some good products. Grows well.
BUY
BUY
January 18, 2002
Not cheap. Good stability. Good product development skills.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
January 18, 2002
Not cheap. Good stability. Good product development skills.
STRONG BUY
STRONG BUY
January 11, 2002
Steady earnings. Demographics on health needs are good.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
January 11, 2002
Steady earnings. Demographics on health needs are good.
DON'T BUY
DON'T BUY
January 2, 2002
A bit expensive, but a good hold. Buy near $50.
Show full opinionHide full opinion
A bit expensive, but a good hold. Buy near $50.
DON'T BUY
DON'T BUY
December 28, 2001
Had a nice run. Probably near its top.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 28, 2001
Had a nice run. Probably near its top.
DON'T BUY
DON'T BUY
December 27, 2001
Fair Market Value = $78. Could break through. Caution.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 27, 2001
Fair Market Value = $78. Could break through. Caution.
DON'T BUY
DON'T BUY
December 10, 2001
Investors are moving out of these defensive stocks.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 10, 2001
Investors are moving out of these defensive stocks.
Showing 421 to 435 of 444 entries